These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23492735)

  • 1. Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiency.
    Rovner AJ; Schall JI; Mondick JT; Zhuang H; Mascarenhas MR
    J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):81-4. PubMed ID: 23492735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal transit times and motility in patients with cystic fibrosis.
    Hedsund C; Gregersen T; Joensson IM; Olesen HV; Krogh K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):920-6. PubMed ID: 22746323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of small-bowel transit scintigraphy to gastric emptying for assessment of patients with upper gastrointestinal symptoms.
    Maurer AH; Yu D; Lu X; Dadparvar S; Kamat BH; Shahsavari D; Parkman HP
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13987. PubMed ID: 32996253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
    Graff GR; McNamara J; Royall J; Caras S; Forssmann K
    Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency.
    Abrams CK; Hamosh M; Hubbard VS; Dutta SK; Hamosh P
    J Clin Invest; 1984 Feb; 73(2):374-82. PubMed ID: 6699170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
    Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
    Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.
    Nicolo M; Stratton KW; Rooney W; Boullata J
    Nutr Clin Pract; 2013 Aug; 28(4):485-9. PubMed ID: 23753650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study.
    Park MI; Ferber I; Camilleri M; Allenby K; Trillo R; Burton D; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Jan; 18(1):28-36. PubMed ID: 16371080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
    Haupt ME; Kwasny MJ; Schechter MS; McColley SA
    J Pediatr; 2014 May; 164(5):1110-1115.e1. PubMed ID: 24560182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
    Borowitz D; Stevens C; Brettman LR; Campion M; Wilschanski M; Thompson H;
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):248-57. PubMed ID: 22266487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children.
    Chitkara DK; Delgado-Aros S; Bredenoord AJ; Cremonini F; El-Youssef M; Freese D; Camilleri M
    J Pediatr; 2003 Nov; 143(5):609-13. PubMed ID: 14615731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Strausbaugh SD; Woo MS; Tong SY; Silber SA; Mulberg AE; Leitz G
    J Cyst Fibros; 2011 Sep; 10(5):350-6. PubMed ID: 21632288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S
    J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
    Borowitz D; Stevens C; Brettman LR; Campion M; Chatfield B; Cipolli M;
    J Cyst Fibros; 2011 Dec; 10(6):443-52. PubMed ID: 21831726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.